Sort
82,697 grants matching “vaccine development”
DRW HIV-Ab/HCV-Ab/HBsAg Triplex Rapid Test Submission for FDA-PMA Approval
$1,075,162Helen H Lee · Diagnostics For The Real World, Ltd · R44 · FY2010 · HL
HIV Prevention Trials Network: Network Laboratory
$1,074,961Susan H Eshleman · Johns Hopkins University · UM1 · FY2013 · AI
Structure-guided vaccine design of HCV E1E2 to induce broadly neutralizing antibodies (bNAbs)
$1,074,915Steven Foung · Stanford University · U19 · FY2024 · AI
World Reference Center for Emerging Viruses and Arboviruses (WRCEVA)
$1,074,805Scott C Weaver · University Of Texas Med Br Galveston · R24 · FY2018 · AI
Vaccine and Monoclonal Antibody Studies in HIV-infected Subjects
$1,074,746Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Cancer Biomaterials Engineering
$1,074,592Matthew Wolf · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Genomics and Computational Biology
$1,074,547William Nicholas Haining · Emory University · U19 · FY2011 · AI
Project 1: PREVENT Program Critical Path Project
$1,074,483Daniel Tuse · University Of Louisville · U19 · FY2017 · AI
Immunobiology and immunotherapy of leukemia
$1,074,460Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
Characterization and improvement of graft versus leukemia effects
$1,074,460Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
SURGERY, IMMUNOLOGY AND IMMUNOTHERAPY OF HUMAN CANCER
$1,074,235Donald L Morton · Saint John'S Cancer Institute · P01 · FY2010 · CA
MFB: Accelerating the Discovery of Novel Liposome Formations with Origins-of-Life Insights, Laboratory Automation, and Machine Learning
$1,074,218Joshua Schrier · Fordham University · · FY2022 · MPS
MOLECULAR THERAPEUTICS OF RHEUMATOID ARTHRITIS
$1,074,215University Of California San Diego · P50 · FY2000 · AR
Quantify the Fraction of Proviruses That Express HIV RNA to Better Understand Proviral Latency and Its Reversal
$1,073,659Mary Kearney · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Environmental influences on fertility and reproductive health
$1,073,602Anne Marie Jukic · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES
iPS cell based immunotherapy for malignant gliomas
$1,073,572John Park · National Institute Of Neurological Disorders And Stroke · ZIA · FY2012 · NS
PEDIATRIC AIDS CLINICAL TRIALS GROUP
$1,073,526St. Jude Children'S Research Hospital · U01 · FY2000 · AI
Clinical and mechanistic studies defining optimal preparative approaches to infants with IL2RG/JAK3/RAG1/RAG2 SCID: a randomized trial of busulfan dosage
$1,072,951Jeffery J Auletta · National Marrow Donor Program · U01 · FY2024 · AI
Laboratory Studies of Human Respiratory Syncytial Virus and Other Pneumoviruses
$1,072,901Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Vaccine Discovery for Chagas Disease
$1,072,658Rick L Tarleton · University Of Georgia · P01 · FY2006 · AI
Antigen-Adjuvant Formulation and Characterization Studies
$1,072,626Antu Dey · International Aids Vaccine Initiative · N01 · FY2019 · AI
Vaccines and Therapeutics for Nipah and Hendra virus
$1,072,517Christopher Broder · Henry M. Jackson Fdn For The Adv Mil/Med · U01 · FY2012 · AI
Studies of Chemokine-Receptor Interactions with Chemokines and alarmins
$1,072,297Joost J Oppenheim · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
PATHOGENESIS AND PREVENTION OF AUTOIMMUNE DIABETES
$1,072,209Yale University · P01 · FY2001 · DK
Efficacy of Oral CMV/SIV Vectors
$1,072,161Louis J. Picker · Oregon Health & Science University · R01 · FY2014 · DE